HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James M Hinson Selected Research

SNX-5422

12/2021Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers.
8/2013Phase I trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James M Hinson Research Topics

Disease

2Neoplasms (Cancer)
12/2021 - 08/2013
2Ischemic Stroke
01/2019 - 11/2014
1Lung Neoplasms (Lung Cancer)
12/2021
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019
1Stroke (Strokes)
01/2019
1Ischemia
11/2014
1Hematologic Neoplasms (Hematological Malignancy)
08/2013

Drug/Important Bio-Agent (IBA)

2SNX-5422IBA
12/2021 - 08/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2021 - 08/2013
1Carboplatin (JM8)FDA LinkGeneric
12/2021
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1salicylhydroxamic acid (SHAM)IBA
01/2019
1Aldehyde DehydrogenaseIBA
11/2014
1Proteins (Proteins, Gene)FDA Link
08/2013

Therapy/Procedure

2Therapeutics
12/2021 - 11/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019
1Catheters
11/2014